Brief: BIORETEC says CEO Alan Donze To Resign Effective July 7, 2025
15/05/2025 06:07
May 15 (Reuters) - Bioretec Oy BRETEC.HE: BIORETEC LTD'S BUSINESS REVIEW Q1 2025: STRONG NET SALES IN THE FIRST QUARTER; CE APPROVAL WITH COMPREHENSIVE INDICATIONS RECEIVED IN JANUARY ACCELERATES THE FUTURE EXPANSION OF REMEOS PRODUCTS Source text: ID:nWkr54m53j Further company coverage: BRETEC.HE ((Reuters.Briefs@thomsonreuters.com;))